Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.31 AUD | 0.00% | +1.32% | -20.07% |
May. 28 | Ord Minnett Starts Australian Clinical Labs at Buy, Price Target is AU$3.50 | MT |
May. 21 | Australian Clinical Expects Fiscal 2024 Earnings to Fall at Lower End of Forecast | MT |
Business Summary
Number of employees: 5,115
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pathology
97.2
%
| 977 | 98.1 % | 678 | 97.2 % | -30.60% |
Clinic
2.1
%
| 13 | 1.3 % | 14 | 2.1 % | +12.86% |
Other
0.6
%
| 6 | 0.6 % | 4 | 0.6 % | -27.59% |
Rental
0.1
%
| 1 | 0.1 % | 1 | 0.1 % | +34.88% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 996 | 100.0 % | 697 | 100.0 % | -29.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Melinda McGrath
CEO | Chief Executive Officer | - | 14-12-31 |
James Davison
DFI | Director of Finance/CFO | - | 14-12-31 |
Tony Landgren
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-31 |
Sean Jackson
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Anthony Friedli
COO | Chief Operating Officer | - | 15-12-31 |
Joe Geran
SAM | Sales & Marketing | - | 14-12-31 |
Eric Swayn
PRN | Corporate Officer/Principal | - | 14-12-31 |
Shae Seymour
PRN | Corporate Officer/Principal | - | 17-12-31 |
Chris Brownlow
PRN | Corporate Officer/Principal | - | 10-12-31 |
Eleanor Padman
SEC | Corporate Secretary | - | 21-04-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Alscher
CHM | Chairman | 56 | 14-12-31 |
Leanne Rowe
BRD | Director/Board Member | 67 | 21-04-27 |
Director/Board Member | - | 23-08-22 | |
Andrew Dutton
BRD | Director/Board Member | - | 21-04-27 |
Director/Board Member | - | 18-03-31 | |
Mark Haberlin
BRD | Director/Board Member | 61 | 21-04-27 |
Melinda McGrath
CEO | Chief Executive Officer | - | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 201,834,015 | 112,103,363 ( 55.54 %) | 1,330,743 ( 0.6593 %) | 55.54 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
HEALIUS LIMITED 4.99% | 36,230,451 | 4.99% | 30,600,601 $ |
2,318,243 | 1.15% | 3,530,591 $ |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.07% | 306M | |
+26.08% | 89.38B | |
-23.66% | 75.67B | |
+7.68% | 28.83B | |
+5.81% | 18.25B | |
-13.80% | 16.51B | |
+2.60% | 15.72B | |
+78.26% | 13.71B | |
+82.29% | 13.46B | |
+4.45% | 12.4B |
- Stock Market
- Equities
- ACL Stock
- Company Australian Clinical Labs Limited